SCHEMBL15782898

SCHEMBL15782898

Cc1cc(OC2CCOCC2)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.44
APP P05067 1/20 0.43
FFAR1 O14842 3/20 0.42
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
MAPK14 Q16539 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GRM5 P41594 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
HRH3 Q9Y5N1 2/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
EGFR P00533 1/20 0.38
PDE2A O00408 1/20 0.38
PDE10A Q9Y233 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26343566 0.91 ACACB (0.42) FFAR1HTR2CHTR2BGRM5HRH3
SCHEMBL16483442 0.88 HTR2C (0.46) HTR2CHTR2BPTGS1PTGS2HRH3
SCHEMBL169750 0.87 SYK (0.44) SYKAPPFFAR1MAPK14GRM5
SCHEMBL6566407 0.85 PTGS1 (0.51) APPHTR2CHTR2BPTGS1PTGS2
SCHEMBL16483457 0.85 PTGS1 (0.48) APPFFAR1HTR2CHTR2BPTGS1
SCHEMBL15785548 0.85 APP (0.45) SYKAPPFFAR1MAPK14PTGS1
SCHEMBL18957032 0.81 RAF1 (0.44) SYKAPPFFAR1TSHRGRM5
SCHEMBL28691522 0.81 APP (0.43) SYKAPPFFAR1MAPK14GRM5
SCHEMBL17669372 0.81 SYK (0.41) SYKFFAR1GRM5HRH3PDE2A
SCHEMBL29416715 0.81 APP (0.43) SYKAPPFFAR1MAPK14GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140163025-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163025-A1 INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS GPR119, GPBAR1, GPR52 SYK 4442/4885APP 2900/4885FFAR1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.